108 related articles for article (PubMed ID: 10571256)
1. Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors.
Hedlund PB; Carson MJ; Sutcliffe JG; Thomas EA
Biochem Pharmacol; 1999 Dec; 58(11):1807-13. PubMed ID: 10571256
[TBL] [Abstract][Full Text] [Related]
2. Oleamide-induced modulation of 5-hydroxytryptamine receptor-mediated signaling.
Thomas EA; Carson MJ; Sutcliffe JG
Ann N Y Acad Sci; 1998 Dec; 861():183-9. PubMed ID: 9928256
[TBL] [Abstract][Full Text] [Related]
3. Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide.
Thomas EA; Carson MJ; Neal MJ; Sutcliffe JG
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14115-9. PubMed ID: 9391162
[TBL] [Abstract][Full Text] [Related]
4. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.
Cheer JF; Cadogan AK; Marsden CA; Fone KC; Kendall DA
Neuropharmacology; 1999 Apr; 38(4):533-41. PubMed ID: 10221757
[TBL] [Abstract][Full Text] [Related]
5. No hypothermic response to serotonin in 5-HT7 receptor knockout mice.
Hedlund PB; Danielson PE; Thomas EA; Slanina K; Carson MJ; Sutcliffe JG
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1375-80. PubMed ID: 12529502
[TBL] [Abstract][Full Text] [Related]
6. Pindolol-insensitive [3H]-5-hydroxytryptamine binding in the rat hypothalamus; identity with 5-hydroxytryptamine7 receptors.
Clemett DA; Kendall DA; Cockett MI; Marsden CA; Fone KC
Br J Pharmacol; 1999 May; 127(1):236-42. PubMed ID: 10369478
[TBL] [Abstract][Full Text] [Related]
7. Oleamide-mediated sleep induction does not depend on perturbation of membrane homeoviscosity.
Gobbi M; Mennini T; Valle FD; Cervo L; Salmona M; Diomede L
FEBS Lett; 1999 Dec; 463(3):281-4. PubMed ID: 10606738
[TBL] [Abstract][Full Text] [Related]
8. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
9. Allosteric Inhibition of Serotonin 5-HT
Satała G; Duszyńska B; Lenda T; Nowak G; Bojarski AJ
Mol Neurobiol; 2018 Apr; 55(4):2897-2910. PubMed ID: 28455702
[TBL] [Abstract][Full Text] [Related]
10. Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus?
Gobbi M; Parotti L; Mennini T
Mol Pharmacol; 1996 Mar; 49(3):556-9. PubMed ID: 8643096
[TBL] [Abstract][Full Text] [Related]
11. Allosteric modulation of the human 5-HT(7A) receptor by lipidic amphipathic compounds.
Alberts GL; Chio CL; Im WB
Mol Pharmacol; 2001 Dec; 60(6):1349-55. PubMed ID: 11723242
[TBL] [Abstract][Full Text] [Related]
12. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.
Sleight AJ; Carolo C; Petit N; Zwingelstein C; Bourson A
Mol Pharmacol; 1995 Jan; 47(1):99-103. PubMed ID: 7838138
[TBL] [Abstract][Full Text] [Related]
13. The endogenous lipid oleamide activates serotonin 5-HT7 neurons in mouse thalamus and hypothalamus.
Thomas EA; Cravatt BF; Sutcliffe JG
J Neurochem; 1999 Jun; 72(6):2370-8. PubMed ID: 10349846
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide.
Boger DL; Patterson JE; Jin Q
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4102-7. PubMed ID: 9539697
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
Adham N; Zgombick JM; Bard J; Branchek TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.
Crider JY; Williams GW; Drace CD; Katoli P; Senchyna M; Sharif NA
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4837-44. PubMed ID: 14578406
[TBL] [Abstract][Full Text] [Related]
17. Positive allosteric modulator of the human 5-HT2C receptor.
Im WB; Chio CL; Alberts GL; Dinh DM
Mol Pharmacol; 2003 Jul; 64(1):78-84. PubMed ID: 12815163
[TBL] [Abstract][Full Text] [Related]
18. Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists.
Romero G; Pujol M; Pauwels PJ
Naunyn Schmiedebergs Arch Pharmacol; 2006 Oct; 374(1):31-9. PubMed ID: 16967291
[TBL] [Abstract][Full Text] [Related]
19. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.
Ruat M; Traiffort E; Leurs R; Tardivel-Lacombe J; Diaz J; Arrang JM; Schwartz JC
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8547-51. PubMed ID: 8397408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
